Literature DB >> 19217123

Characterization of surgical procedures in patients with mucopolysaccharidosis type I: findings from the MPS I Registry.

Pamela Arn1, J Edmond Wraith, Lisa Underhill.   

Abstract

OBJECTIVE: To clarify the extent and chronology of surgical burden in relation to symptom onset and diagnosis in patients with mucopolysaccharidosis I (MPS I) as reported in the MPS I Registry, an international observational database. STUDY
DESIGN: Analysis of surgical data from 544 patients enrolled in the MPS I Registry. Among all patients with at least 1 reported surgery, the number and frequency of procedures, and age at procedure, diagnosis, and symptom onset were collected overall, by patient, and by reported phenotype (Hurler, Hurler-Scheie, Scheie).
RESULTS: Overall and by phenotype, approximately 75% of patients in the MPS I Registry reported at least 1 surgery. The most common were myringotomies and related procedures, hernia repair, adenoidectomy/tonsillectomy, and carpal-tunnel release. Median age at first surgery was <5 years. A median of 3 to 4 surgeries was reported per patient. By age 1.5, 4, and 10 years, respectively, 22%, 44%, and 54% of patients reported > or = 2 surgeries. At least 1 surgery preceded diagnosis in 36%, 46%, and 63% of patients with Hurler, Hurler-Scheie, and Scheie, respectively.
CONCLUSIONS: Pediatricians and pediatric surgeons need to be aware of the surgical burden of MPS I and be alert to its presenting signs and symptoms in children scheduled for surgery.

Entities:  

Mesh:

Year:  2009        PMID: 19217123     DOI: 10.1016/j.jpeds.2008.12.024

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  23 in total

1.  The effect of neonatal gene therapy on skeletal manifestations in mucopolysaccharidosis VII dogs after a decade.

Authors:  Elizabeth M Xing; Van W Knox; Patricia A O'Donnell; Tracey Sikura; Yuli Liu; Susan Wu; Margret L Casal; Mark E Haskins; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2013-04-06       Impact factor: 4.797

2.  Adverse Effects of Genistein in a Mucopolysaccharidosis Type I Mouse Model.

Authors:  Sandra D K Kingma; Tom Wagemans; Lodewijk IJlst; Jurgen Seppen; Marion J J Gijbels; Frits A Wijburg; Naomi van Vlies
Journal:  JIMD Rep       Date:  2015-04-09

Review 3.  Anesthesia for patients with mucopolysaccharidoses: Comprehensive review of the literature with emphasis on airway management.

Authors:  Brittney M Clark; Juraj Sprung; Toby N Weingarten; Mary E Warner
Journal:  Bosn J Basic Med Sci       Date:  2018-02-20       Impact factor: 3.363

Review 4.  Disease registries and outcomes research in children: focus on lysosomal storage disorders.

Authors:  Simon Jones; Emma James; Suyash Prasad
Journal:  Paediatr Drugs       Date:  2011-02-01       Impact factor: 3.022

5.  Pathogenesis of mitral valve disease in mucopolysaccharidosis VII dogs.

Authors:  Paul W Bigg; Guilherme Baldo; Meg M Sleeper; Patricia A O'Donnell; Hanqing Bai; Venkata R P Rokkam; Yuli Liu; Susan Wu; Roberto Giugliani; Margret L Casal; Mark E Haskins; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2013-06-25       Impact factor: 4.797

6.  Childhood onset of Scheie syndrome, the attenuated form of mucopolysaccharidosis I.

Authors:  Janet A Thomas; Michael Beck; Joe T R Clarke; Gerald F Cox
Journal:  J Inherit Metab Dis       Date:  2010-06-02       Impact factor: 4.982

7.  The effect of neonatal gene therapy with a gamma retroviral vector on cardiac valve disease in mucopolysaccharidosis VII dogs after a decade.

Authors:  Paul W Bigg; Meg M Sleeper; Patricia A O'Donnell; Yuli Liu; Susan Wu; Margret L Casal; Mark E Haskins; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2013-06-25       Impact factor: 4.797

8.  Effects of neonatal enzyme replacement therapy and simvastatin treatment on cervical spine disease in mucopolysaccharidosis I dogs.

Authors:  Joseph A Chiaro; Patricia O'Donnell; Eileen M Shore; Neil R Malhotra; Katherine P Ponder; Mark E Haskins; Lachlan J Smith
Journal:  J Bone Miner Res       Date:  2014-12       Impact factor: 6.741

Review 9.  Mucopolysaccharidoses.

Authors:  Rolando Cimaz; Francesco La Torre
Journal:  Curr Rheumatol Rep       Date:  2014-01       Impact factor: 4.592

10.  Upregulation of elastase activity in aorta in mucopolysaccharidosis I and VII dogs may be due to increased cytokine expression.

Authors:  Jason A Metcalf; Bruce Linders; Susan Wu; Paul Bigg; Patricia O'Donnell; Meg M Sleeper; Michael P Whyte; Mark Haskins; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2009-12-11       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.